2023
CyberKnife Stereotactic Radiosurgery for Growing Vestibular Schwannoma: Longitudinal Tumor Control, Hearing Outcomes, and Predicting Post‐Treatment Hearing Status
Hildrew D, Perez P, Mady L, Li J, Nilsen M, Hirsch B. CyberKnife Stereotactic Radiosurgery for Growing Vestibular Schwannoma: Longitudinal Tumor Control, Hearing Outcomes, and Predicting Post‐Treatment Hearing Status. The Laryngoscope 2023, 134: s1-s12. PMID: 37178050, DOI: 10.1002/lary.30731.Peer-Reviewed Original ResearchMeSH KeywordsFollow-Up StudiesHearingHearing LossHumansNeuroma, AcousticRadiosurgeryRetrospective StudiesTreatment OutcomeConceptsTumor control rateCyberKnife stereotactic radiosurgeryHearing outcomesVestibular schwannomaControl rateStereotactic radiosurgeryRetrospective case series reviewCase series reviewThird of patientsProportional hazard modelingMaximum radiation doseSeries reviewTumor controlAvailable audiogramsOtolaryngology-HeadTumor volumeEffective treatmentClass APatientsHearing statusAmerican AcademyHazard modelingVolumetric analysisRadiation doseOutcomes
2016
Development of an evidence-based decision pathway for vestibular schwannoma treatment options
Linkov F, Valappil B, McAfee J, Goughnour SL, Hildrew DM, McCall AA, Linkov I, Hirsch B, Snyderman C. Development of an evidence-based decision pathway for vestibular schwannoma treatment options. American Journal Of Otolaryngology 2016, 38: 57-64. PMID: 27780583, DOI: 10.1016/j.amjoto.2016.09.019.Peer-Reviewed Original ResearchConceptsVestibular schwannomaGroup of patientsPost-operative symptomsEvidence-based dataPittsburgh Medical CenterEffectiveness of treatmentQuality of lifeComplex medical problemsHealth care systemTreatment Decision Support SystemVS patientsTreatment optionsTreatment pathwaysTreatment decisionsMedical CenterClinical informationTreatment selectionFocus groupsSide effectsPatient valuesPatientsPatient feedbackClinical investigatorsTreatment alternativesMedical problems